Harriet Edwards explores the current landscape for genome editing technologies
An article authored by Harriet Edwards, Associate Director of Regulatory Affairs at Boyds, has been published in Cell & Gene Therapy Insights. In the viewpoint article: ‘2024: the year of the genome editing technologies?’ Harriet looks at the current landscape for genome editing, the regulation surrounding it, and key considerations for regulators and developers as […]
How To De-Risk Your IND Webinar
On March 20, 2024 at 9 am PST, Boyds will host a webinar designed to provide attendees with a plan of action that can help to de-risk your Investigational New Drug (IND) application and expedite the path to gain study clearance.
Boyds is now a proud member of MassBio
As part of our continued growth plans in the US, Boyds is delighted to join MassBio as a proud member.
Boyds shortlisted for BioNow Business Support Award
Boyds is delighted to have been named as a finalist in the Business Support category of the BioNow Awards 2023.
Boyds joins Texas Healthcare and Bioscience Institute (THBI) as proud member
Boyds is delighted to have been named as a finalist in the Business Support category of the BioNow Awards 2023.
Meet the Medics
In this new interview series, we sit down and meet the medics at Boyds to find out about their career backgrounds, their interest and passion for medicine, their greatest achievement – whether personal or professional – and get their insights on the latest industry trends.
Boyds collaborates with BioPharma Connections
Boyds partners with BioPharma Connections in the company’s latest move to continue its growth in the U.S.
Double win for Boyds at TOPRA Awards 2023
The TOPRA Awards 2023 saw the Boyds team take home two awards, with our regulatory affairs team crowned winners of the Futures Award and our Senior Director of Regulatory Affairs Katherine Bowen awarded the Inspiration Award. The TOPRA Awards for Regulatory Excellence are the annual international awards for celebrating achievement and best practice in regulatory […]
Boyds grows regulatory affairs team with new hire
We are delighted to announce the appointment of Monica Pianella as Associate Director of Regulatory Affairs. With over seven years’ experience in advanced therapies, Monica joins Boyds from the Cell and Gene Therapy Catapult (CGTC) where she was Senior Regulatory Affairs Manager working in early drug development with a strong focus on CMC and cell […]
Boyds launches ‘Conversations in Drug Development’ podcast
Boyds has announced the launch of a brand-new podcast series that aims to keep the scientific and clinical community abreast of the latest advancements in cell and gene therapy and drug development.
